FULC - Fulcrum upgraded by Goldman Sachs ahead of Phase 3 data
2024-05-13 17:52:17 ET
More on Fulcrum Therapeutics
- Fulcrum Therapeutics, Inc. (FULC) Q1 2024 Earnings Call Transcript
- Fulcrum Therapeutics, Inc. (FULC) Q4 2023 Earnings Call Transcript
- Sanofi gains license for ex-U.S. rights to Fulcrum muscular dystrophy candidate
- Fulcrum Therapeutics GAAP EPS of -$0.43 in-line
- Seeking Alpha’s Quant Rating on Fulcrum Therapeutics